Page 222 - Read Online

Page 16 of 17 Matsushita et al. Hepatoma Res 2018;4:61 I http://dx.doi.org/10.20517/2394-5079.2018.81

26. Fiorentino DF, Presby M, Baer AN, Petri M, Rieger KE, Soloski M, Rosen A, Mammen AL, Christopher-Stine L, Casciola-Rosen L.
PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sjögren’s syndrome. Ann Rheum Dis 2016;75:1145-
51.
27. Kobayashi S, Hoshino T, Hiwasa T, Satoh M, Rahmutulla B, Tsuchida S, Komukai Y, Tanaka T, Matsubara H, Shimada H, Nomura F,
Matsushita K. Anti-FIRs (PUF60) auto-antibodies are detected in the sera of early-stage colon cancer patients. Oncotarget 2016;7:82493-
503.
28. Kobayashi S, Hiwasa T, Arasawa T, Kagaya A, Ishii S, Shimada H, Ito M, Suzuki M, Kano M, Rahmutulla B, Kitamura K, Sawabe Y,
Shin H, Takiguchi M, Nomura F, Matsubara H, Matsushita K. Identification of specific and common diagnostic antibody markers for
gastrointestinal cancers by SEREX screening using testis cDNA phage library. Oncotarget 2018;9:18559-69.
29. Matsushita K, Tamura M, Tanaka N, Tomonaga T, Matsubara H, Shimada H, Levens D, He L, Liu J, Yoshida M, Nomura F. Interactions
between SAP155 and FUSE-binding protein-interacting repressor bridges c-Myc and P27Kip1 expression. Mol Cancer Res 2013;11:689-
98.
30. Kajiwara T, Matsushita K, Itoga S, Tamura M, Tanaka N, Tomonaga T, Matsubara H, Shimada H, Habara Y, Matsuo M, Nomura F.
SAP155-mediated c-Myc suppressor far-upstream element-binding protein-interacting repressor splicing variants are activated in colon
cancer tissues. Cancer Sci 2013;104:149-56.
31. Matsushita K, Kajiwara T, Tamura M, Satoh M, Tanaka N, Tomonaga T, Matsubara H, Shimada H, Yoshimoto R, Ito A, Kubo S, Natsume
T, Levens D, Yoshida M, Nomura F. SAP155-mediated splicing of FUSE-binding protein-interacting repressor serves as a molecular switch
for c-Myc gene expression. Mol Cancer Res 2012;10:787-99.
32. Kotake Y, Sagane K, Owa T, Mimori-Kiyosue Y, Shimizu H, Uesugi M, Ishihama Y, Iwata M, Mizui Y. Splicing factor SF3b as a target of
the antitumor natural product pladienolide. Nat Chem Biol 2007;3:570-5.
33. Kaida D, Motoyoshi H, Tashiro E, Nojima T, Hagiwara M, Ishigami K, Watanabe H, Kitahara T, Yoshida T, Nakajima H, Tani T, Horinouchi
S, Yoshida M. Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA. Nat Chem Biol 2007;3:576-83.
34. Sun S, Nakashima K, Ito M, Li Y, Chida T, Takahashi H, Watashi K, Sawasaki T, Wakita T, Suzuki T. Involvement of PUF60 in
transcriptional and post-transcriptional regulation of hepatitis B virus pregenomic RNA expression. Sci Rep 2017;7:12874.
35. Kanoh N, Kumashiro S, Simizu S, Kondoh Y, Hatakeyama S, Tashiro H, Osada H. Immobilization of natural products on glass slides by
using a photoaffinity reaction and the detection of protein-small-molecule interactions. Angew Chem Int Ed Engl 2003;42:5584-7.
36. Osada H. Introduction of new tools for chemical biology research on microbial metabolites. Biosci Biotechnol Biochem 2010;74:1135-40.
37. Kawatani M, Fukushima Y, Kondoh Y, Honda K, Sekine T, Yamaguchi Y, Taniguchi N, Osada H. Identification of matrix metalloproteinase
inhibitors by chemical arrays. Biosci Biotechnol Biochem 2015;79:1597-602.
38. Malz M, Bovet M, Samarin J, Rabenhorst U, Sticht C, Bissinger M, Roessler S, Bermejo JL, Renner M, Calvisi DF, Singer S, Ganzinger
M, Weber A, Gretz N, Zörnig M, Schirmacher P, Breuhahn K. Overexpression of far upstream element (FUSE) binding protein (FBP)-
interacting repressor (FIR) supports growth of hepatocellular carcinoma. Hepatology 2014;60:1241-50.
39. Loerch S, Kielkopf CL. Unmasking the U2AF homology motif family: a bona fide protein-protein interaction motif in disguise. RNA
2016;22:1795-807.
40. Stepanyuk GA, Serrano P, Peralta E, Farr CL, Axelrod HL, Geralt M, Das D, Chiu HJ, Jaroszewski L, Deacon AM, Lesley SA, Elsliger
MA, Godzik A, Wilson IA, Wüthrich K, Salomon DR, Williamson JR. UHM-ULM interactions in the RBM39-U2AF65 splicing-factor
complex. Acta Crystallogr D Struct Biol 2016;72:497-511.
41. Loerch S, Maucuer A, Manceau V, Green MR, Kielkopf CL. Cancer-relevant splicing factor CAPERα engages the essential splicing factor
SF3b155 in a specific ternary complex. J Biol Chem 2014;289:17325-37.
42. Corsini L, Hothorn M, Stier G, Rybin V, Scheffzek K, Gibson TJ, Sattler M. Dimerization and protein binding specificity of the U2AF
homology motif of the splicing factor Puf60. J Biol Chem 2009;284:630-9.
43. Matsushita K, Kitamura K, Rahmutulla B, Tanaka N, Ishige T, Satoh M, Hoshino T, Miyagi S, Mori T, Itoga S, Shimada H, Tomonaga
T, Kito M, Nakajima-Takagi Y, Kubo S, Nakaseko C, Hatano M, Miki T, Matsuo M, Fukuyo M, Kaneda A, Iwama A, Nomura F.
Haploinsufficiency of the c-Myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53- dependent
T-cell acute lymphoblastic leukemia progression by activating Notch1. Oncotarget 2015;6:5102-17.
44. Wang Z, Inuzuka H, Fukushima H, Wan L, Gao D, Shaik S, Sarkar FH, Wei W. Emerging roles of the FBW7 tumour suppressor in stem cell
differentiation. EMBO Rep 2011;13:36-43.
45. Wang Z, Inuzuka H, Zhong J, Wan L, Fukushima H, Sarkar FH, Wei W. Tumor suppressor functions of FBW7 in cancer development and
progression. FEBS Lett 2012;586:1409-18.
46. Ogura Y, Hoshino T, Tanaka N, Ailiken G, Kobayashi S, Kitamura K, Rahmutulla B, Kano M, Murakami K, Akutsu Y, Nomura F, Itoga
S, Matsubara H, Matsushita K. Disturbed alternative splicing of FIR (PUF60) directed cyclin E overexpression in esophageal cancers.
Oncotarget 2018;9:22929-44.
47. Yanagita H, Urano E, Matsumoto K, Ichikawa R, Takaesu Y, Ogata M, Murakami T, Wu H, Chiba J, Komano J, Hoshino T. Structural
and biochemical study on the inhibitory activity of derivatives of 5-nitro-furan-2-carboxylic acid for RNase H function of HIV-1 reverse
transcriptase. Bioorg Med Chem 2011;19:816-25.
48. Yanagita H, Fudo S, Urano E, Ichikawa R, Ogata M, Yokota M, Murakami T, Wu H, Chiba J, Komano J, Hoshino T. Structural modulation
study of inhibitory compounds for ribonuclease H activity of human immunodeficiency virus type 1 reverse transcriptase. Chem Pharm Bull
(Tokyo) 2012;60:764-71.
49. Fudo S, Yamamoto N, Nukaga M, Odagiri T, Tashiro M, Neya S, Hoshino T. Structural and computational study on inhibitory compounds
for endonuclease activity of influenza virus polymerase. Bioorg Med Chem 2015;23:5466-75.
50. Kimura A, Kitamura K, Ailiken G, Satoh M, Minamoto T, Tanaka N, Nomura F, Matsushita K. FIR haplodeficiency promotes splicing to
pyruvate kinase M2 in mice thymic lymphoma tissues revealed by six-plex tandem mass tag quantitative proteomic analysis. Oncotarget
2017;8:67955-65.